Global Retirement Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.95M | Buy |
+3,925
| New | +$1.74M | 0.03% | 499 |
|
|
2025
Q4 | $1.97M | Buy |
4,345
+2,012
| +86% | +$867K | 0.04% | 436 |
|
|
2025
Q3 | $914K | Buy |
2,333
+128
| +6% | +$53.5K | 0.02% | 565 |
|
|
2025
Q2 | $982K | Buy |
+2,205
| New | +$1.02M | 0.02% | 517 |
|
|
2024
Q4 | $776K | Sell |
1,926
-530
| -22% | -$246K | 0.02% | 503 |
|
|
2024
Q3 | $1.14M | Sell |
2,456
-291
| -11% | -$140K | 0.03% | 414 |
|
|
2024
Q2 | $1.29M | Buy |
2,747
+1,438
| +110% | +$624K | 0.04% | 367 |
|
|
2024
Q1 | $547K | Buy |
1,309
+130
| +11% | +$55K | 0.02% | 513 |
|
|
2023
Q4 | $516K | Sell |
1,179
-15
| -1% | -$5.54K | 0.02% | 492 |
|
|
2023
Q3 | $421K | Buy |
1,194
+264
| +28% | +$92.3K | 0.02% | 471 |
|
|
2023
Q2 | $327K | Sell |
930
-14
| -1% | -$4.72K | 0.02% | 545 |
|
|
2023
Q1 | $327K | Buy |
944
+171
| +22% | +$51.3K | 0.02% | 530 |
|
|
2022
Q4 | $223K | Sell |
773
-207
| -21% | -$63.1K | 0.02% | 568 |
|
|
2022
Q3 | $306K | Buy |
980
+422
| +76% | +$121K | 0.02% | 462 |
|
|
2022
Q2 | $157K | Sell |
558
-126
| -18% | -$33.7K | 0.01% | 619 |
|
|
2022
Q1 | $184K | Buy |
+684
| New | +$162K | 0.01% | 575 |
|
|
2021
Q4 | – | Sell |
-850
| Closed | -$154K | – | 1770 |
|
|
2021
Q3 | $154K | Buy |
850
+574
| +208% | +$112K | 0.02% | 535 |
|
|
2021
Q2 | $56K | Buy |
276
+5
| +2% | +$1.05K | 0.01% | 809 |
|
|
2021
Q1 | $58K | Sell |
271
-260
| -49% | -$57.1K | 0.01% | 733 |
|
|
2020
Q4 | $125K | Buy |
531
+94
| +22% | +$21.6K | 0.02% | 479 |
|
|
2020
Q3 | $119K | Hold |
437
| – | – | 0.02% | 453 |
|
|
2020
Q2 | $127K | Buy |
437
+277
| +173% | +$75.1K | 0.02% | 440 |
|
|
2020
Q1 | $38K | Hold |
160
| – | – | 0.01% | 633 |
|
|
2019
Q4 | $35K | Hold |
160
| – | – | 0.01% | 748 |
|
|
2019
Q3 | $27K | Sell |
160
-122
| -43% | -$21.6K | ﹤0.01% | 798 |
|
|
2019
Q2 | $52K | Sell |
282
-2
| -0.7% | -$350 | 0.01% | 600 |
|
|
2019
Q1 | $52K | Buy |
284
+137
| +93% | +$25.3K | 0.01% | 541 |
|
|
2018
Q4 | $24K | Buy |
147
+28
| +24% | +$4.85K | 0.01% | 696 |
|
|
2018
Q3 | $23K | Buy |
119
+11
| +10% | +$1.96K | 0.01% | 771 |
|
|
2018
Q2 | $18K | Buy |
108
+72
| +200% | +$11.2K | ﹤0.01% | 832 |
|
|
2018
Q1 | $6K | Sell |
36
-56
| -61% | -$9.15K | ﹤0.01% | 1126 |
|
|
2017
Q4 | $14K | Buy |
+92
| New | +$13.6K | ﹤0.01% | 812 |
|
Other funds holding VRTX
Global Retirement Partners's VRTX Position: Q2 2026 in Review
Global Retirement Partners opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 3,925 shares worth $1.95M. The stake represents 0.03% of the portfolio and ranks #499 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in VRTX as recently as Q4 2025.
Global Retirement Partners first reported a position in VRTX in Q4 2017 and has held it in 32 quarters since. The position peaked at $1.97M in Q4 2025. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Global Retirement Partners held 3,925 shares of Vertex Pharmaceuticals worth $1.95M as of Q2 2026.
- Vertex Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
- Vertex Pharmaceuticals made up 0.03% of Global Retirement Partners's portfolio in Q2 2026, its #499 holding.
- Global Retirement Partners first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 32 quarters since.
- Global Retirement Partners's Vertex Pharmaceuticals position peaked at $1.97M in Q4 2025.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.